Загрузка...
New agents for AML and MDS
The heterogeneity of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has led to a multiplicity of treatments, from cytotoxic agents to signal transduction modulators, cell cycle inhibitors, and epigenetic therapies. While some have shown promising initial results, the outlook for AM...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2793080/ https://ncbi.nlm.nih.gov/pubmed/19959100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2009.08.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|